s6y
Company name or ticker
Search
Telomir Pharmaceuticals, Inc.
3
Mushak Andriy: Initial statement of beneficial ownership of securities
Filed
Tuesday, June 9, 2026
Period
Jun 3, 2026
Accession number
0001493152-26-027958
Documents
3
3
On sec.gov
Filing index
All files
Complete submission text
SGML header